WWP1 and Familial prostate cancer: Bortezomib was further reported to prevent bone metastasis of prostate cancer cells by inhibition of the WW domain containing E3 ubiquitin protein ligase 1 (WWP1) and Smurf ligases, which are frequently upregulated in patients with bone metastasis [254].